MorphoSys AG / MorphoSys UK Ltd. / Sloning BioTechnology GmbH / Bio-Rad MorphoSys AG / MorphoSys US Inc. / Bio-Rad Laboratories Inc. / MorphoSys AbD GmbH / Frankfurt Stock Exchange / /
Country
Germany / / /
Event
Company Listing Change / M&A / /
IndustryTerm
pharmaceutical industry / treatment of cancer / human healthcare / pharmaceutical partners / healthcare products / antibody library technology / antibody technology / /
MedicalCondition
Alzheimer’s disease / cancer / rheumatoid arthritis / /
Person
Jens Holstein / / /
Position
Chief Financial Officer / Claudia Gutjahr-Löser Head of Corporate Communications / leader / Alexandra Goller Specialist Corporate Communications / Director Corporate Communications & IR Tel / /
Product
Slonomics / HuCAL / /
Technology
antibody technology / antibodies / antibody library technology / drug development / /
Media Release Martinsried/Munich, Germany, January 10, 2013 MorphoSys Completes Sale of AbD Serotec to Bio-Rad MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that the sale of its research and dia